Skip to content

Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder

Promoting Patient Engagement in Clinical Preventive Services: Evaluating the Use of Healthfinder

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03462186
Enrollment
1092
Registered
2018-03-12
Start date
2018-04-15
Completion date
2019-08-14
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Knowledge, Attitudes, Practice

Brief summary

Clinical preventive services (CPS) are fundamental to early disease detection and improvement of health outcomes but are often poorly understood and utilized by patients. Myhealthfinder is a web-based tool developed by the Office of Disease Prevention and Health Promotion (https://healthfinder.gov). This study tests the prescription of myhealthfinder to engage patients in CPS, improve patient-clinician communication and increase uptake of CPS.

Interventions

OTHERHealthfinder invitation

Invitation to use healthfinder (healthfinder.gov/myhealthfinder

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Scheduled wellness appointment with primary care provider

Exclusion criteria

* Inability to read English

Design outcomes

Primary

MeasureTime frameDescription
Change in communication and health knowledgeImmediately after the interventionPatient survey asking about knowledge of recommended preventive services and communication with clinician; qualitative themes from audio-recordings of clinician-patient visit with subset of randomly selected patients
Uptake of clinical preventive services3 monthsPercent up-to-datedness on cancer screening (cervical, breast, colon, lung cancer); immunizations (influenza, pneumonia) and cardiovascular disease (hypercholesterolemia, diabetes). This will be calculated based on the number of recommended services as identified on the healthfinder website based on age/gender that each patient has received within the recommended time frame.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026